Manufacturers across industries continue to rely heavily upon custom injection molders to help design, engineer, and produce solutions for complex applications. Not every molder is capable of delivering on these expectations, but those that are will undoubtedly insist upon exceptional injection molding quality control.
As a trusted partner to OEMs in medical, automotive, industrial, and consumer markets Kaysun is deeply committed to quality and the processes necessary to maintain it. Through strategic implementation of quality assurance initiatives and continuous improvement cycles, our customers are confident in attaining desired results.
When it comes to designing and launching a new injection-molded part, design engineers can always count on:
- The design drives part performance
- If something goes wrong with the part, the design is the first place to look for answers
- The importance of part design increases considerably with tight tolerance injection molding
No pressure, right?
OEMs across many industries can attest to the benefits of plastic injection molding. It’s ideal for consistent, affordable production of a wide range of high-quality complex plastic parts that can withstand about any environment.
That’s reason enough to rank injection molding high on the list of go-to solutions, but there’s more. To better understand how and why manufacturers use the process, let’s take a look at the individual merits of the top 14 benefits of plastic injection molding (listed in no particular order):
On September 28, 2020, the world reached the sad and sobering milestone of 1 million deaths caused by COVID-19. In the three ensuing months, approximately 625,000 more deaths were added to the tally, and the nearly 73 million active cases around the global are added to daily — and at astounding rates.1
The pandemic has populations scared and experts stymied as to how to manage and eventually eradicate the virus. For obvious reasons the medical and healthcare industries are leading the charge in terms of innovation, with antimicrobial resins and antimicrobial polymers playing major roles in effective solutions.
The consumer market is demanding. The need for and availability of products is largely predicated on economies wherein consumer purchase confidence can be fickle. It leaves consumer market OEMs to balance product quality, performance, and cost to remain competitive.
It also compels them to be purposeful in creating and maintaining their supply chain. Suppliers that have proven proficiencies across a range of needs provide a stable framework upon which an OEM can build a versatile — and valuable — partnership.
The escalation of political, trade, and pandemic-related tensions have called manufacturers and their suppliers into question. Some supply chains are snapping under the strain, and OEMs are left to find answers for — and rectify — costly failures.
Nearly half of respondents to a recent Thomas Industrial poll placed “Fabricated Materials (machined, stamped, extruded, or molded material)” at the top of the list of things needed for supply chain stabilization and consistent production.1 With that comes close scrutiny of custom injection molding companies when OEMs are streamlining suppliers.
Medical device design engineers often make allowances for the impact that the molding process has on plastic part manufacturability. They carefully consider a variety of design factors like the materials chosen, the part shape and features, surface finish, and the properties of the tool itself. So, why involve an injection molder early in the medical device development phase?
Involving an experienced injection molder early in the design process safeguards against adverse outcomes that a designer may not have anticipated.
Globally, the annual injection-molded plastics market is currently valued at approximately $260 billion, with a projected 5% CAGR over the next five years.1
These substantial numbers validate the continued and increasing reliance on injection-molded solutions for a variety of applications across industries. They also indicate how much the role of a custom injection molder has changed, shifting from general supplier to trusted partner.
According to global aging data compiled by the United Nations, by 2050 1 in 6 people in the world will be over the age of 65.1 That's a dramatic jump from current statistics that place the same segment of the population at 1 in 11.1
As a result — and in light of spikes in medical demand due to COVID-19 for all age groups — healthcare is rapidly shifting from clinics and hospitals to in-home care and smaller, non-traditional facilities.